NCT06896695

Brief Summary

This clinical trial compares the effect a financial intervention, called Financial Compass, to usual care in identifying and addressing financial hardship in patients with head and neck cancer. Previous research has shown that head and neck cancer patients experiencing financial hardship have decreased overall and cancer specific survival. Using a financial intervention, Financial Compass, may be more effective than usual care in identifying and addressing financial hardship in patients with head and neck cancer.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
8mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Sep 2025Feb 2027

First Submitted

Initial submission to the registry

March 13, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 26, 2025

Completed
6 months until next milestone

Study Start

First participant enrolled

September 23, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 25, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2027

Last Updated

June 8, 2026

Status Verified

June 1, 2026

Enrollment Period

1.4 years

First QC Date

March 13, 2025

Last Update Submit

June 4, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Development of the Financial Compass intervention (Aim 1)

    Will use stage 1A of the National Institutes of Health Stage Model to further develop the Financial Compass intervention. Will use data from in-depth interviews and collaborative engagement of advisory boards to refine the final Financial Compass intervention package. Will complete the Financial Compass intervention package. Will use the Person, Extended Family, Neighborhood (PEN)-3 model to guide integration of stakeholder feedback into the final Financial Compass intervention package. Will prepare summaries of key findings from the in-depth interviews to review with advisory board members. Themes in advisory board member feedback will be categorized using the main constructs of PEN-3 model in a 3 x 3 table, including (1) perceptions, (2) enablers, and (3) nurturers.

    Up to 2 years

  • Feasibility of the Financial Compass intervention (Aim 2)

    Will assess feasibility of the Financial Compass intervention among head and neck cancer patients. Will examine feasibility through demand (study enrollment rates, reasons for refusal), practicality (retention rates, engagement with intervention sessions/materials, reasons for study drop out), and acceptability (participant satisfaction with intervention materials and content). To assess acceptability, will administer the Acceptability of Intervention Measure (4 items), Intervention Appropriateness Measure (4 items) and Feasibility of Intervention Measure (4 items). The measures use a 5-point Likert scale where 1 = completely disagree and 5 = completely agree and have demonstrated strong psychometric properties. In the Financial Compass group, the measures will be summarized using the appropriate descriptive statistics, with estimates of enrollment and retention rates obtained with 90% confidence intervals.

    Up to 12 weeks

Study Arms (3)

discussion

OTHER

Participants take part in a community advisory board and/or a health care delivery advisory board on study to discuss, develop and refine the Financial Compass intervention.

Other: Discussion

Group I (Financial Compass intervention)

EXPERIMENTAL

Patients receive the Financial Compass intervention on study including a patient needs assessment, a tailored care pathway and weekly individualized navigation and support to access resources.

Other: DiscussionOther: Financial Navigation

Group II (usual care)

ACTIVE COMPARATOR

Patients receive usual care on study including medical consultations and supportive care.

Other: Best PracticeOther: Survey Administration

Interventions

Receive usual care

Also known as: standard of care, standard therapy
Group II (usual care)

Ancillary studies

Also known as: Discuss
Group I (Financial Compass intervention)discussion

Receive the Financial Compass intervention

Also known as: Financial Navigation Program
Group I (Financial Compass intervention)

Ancillary studies

Group II (usual care)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • They have been diagnosed with head and neck cancer
  • Screen positive for financial hardship on the validated Comprehensive Score for Financial Toxicity (COST) measure
  • Are able to participate in English or Spanish

You may not qualify if:

  • Adults unable to complete the process of informed consent
  • Adults whose primary language is not English or Spanish
  • Individuals who are not yet adults (i.e., infants, children, teenagers)
  • Unwilling or unable to follow protocol requirements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Roswell Park Cancer Institute

Buffalo, New York, 14263, United States

RECRUITING

MeSH Terms

Interventions

Practice Guidelines as TopicStandard of Care

Intervention Hierarchy (Ancestors)

Guidelines as TopicQuality Assurance, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and EvaluationQuality Indicators, Health Care

Study Officials

  • Elizabeth Bouchard

    Roswell Park Cancer Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 13, 2025

First Posted

March 26, 2025

Study Start

September 23, 2025

Primary Completion (Estimated)

February 25, 2027

Study Completion (Estimated)

February 25, 2027

Last Updated

June 8, 2026

Record last verified: 2026-06

Locations